Lepu Medical, 원숭이 두 바이러스 검출을위한 형광 정량적 시약 개발
-
2022-08-11
-
LEPU
According to the WHO news announcement, the monkeypox epidemic has found about 26,000 confirmed cases of monkeypox in more than 88 countries and regions, constituting the highest level of alert of "public health event of international concern (PHEIC)"! This has raised concerns about the spread of the virus. According to the WHO, Europe is currently a high-risk area for monkeypox, and the rest of the world is at a medium-risk level.
원숭이의 세계적인 발생에 대응하여 Lepu Medical은 몽크 수두 바이러스에 대한 핵산 테스트 키트 (PCR-Fluorescence Probe Method) 를 개발하고 EU CE 인증을 획득했습니다. 이 시약은 여러 국가의 실험실이 원숭이 두 핵산 검사와 신속한 진단을 효율적으로 수행하는 데 도움이되는 솔루션을 제공합니다.
Lepu Medical's monkeypox virus detection kit has the characteristics of high detection sensitivity, easy operability and strong stability. The kit can be quickly applied on multiple platforms such as Lepgen-96, Roche LightCycler 480 series, Bio-Rad CFX96, Shanghai Hongshi SLAN, and ABI 7500. At present, Lepu Medical has received orders and inquiries from many overseas countries and, at the same time, actively promotes the registration of this product in other overseas countries.
